LoginRegister
    Cadila Healthcare gets 14 USFDA observations for Moraiya plantCadila Healthcare gets 14 USFDA observations for Moraiya plant
    Generic of Sensipar: US court denies Amgen request for preliminary injunction against CiplaGeneric of Sensipar: US court denies Amgen request for preliminary injunction against Cipla
    Narcotics Control Bureau seals illegal Ketamine factory in HyderabadNarcotics Control Bureau seals illegal Ketamine factory in Hyderabad
    USFDA allows sale of breast implants tied to rare cancerUSFDA allows sale of breast implants tied to rare cancer
    Gilead Sciences posts higher Q1 profit; drug sales in line with expectationsGilead Sciences posts higher Q1 profit; drug sales in line with expectations
    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High CourtBiocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court
    Pharma Ex Chairman held guilty of bribing doctors in millions to push opioidPharma Ex Chairman held guilty of bribing doctors in millions to push opioid
    Glenmark expands specialty portfolio with OTIPRIO co-promotion agreement with OtonomyGlenmark expands specialty portfolio with OTIPRIO co-promotion agreement with Otonomy
    Union Health Minister asked not to receive donations from JnJ for TB Control ProgramUnion Health Minister asked not to receive donations from JnJ for TB Control Program
    AbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patientsAbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patients
    Merck Q1 net profit up as cancer drug, vaccine sales soarMerck Q1 net profit up as cancer drug, vaccine sales soar
    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic SolutionAlembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X